This inventor holds 1 USPTO granted patent. Top assignees: Dojindo Laboratories, Fukuoka Prefectural Government, Kyoto University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: The Innovative Contributions of Takeshi Ido
Introduction
Takeshi Ido is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of carriers for introducing compounds into cells. His work emphasizes efficiency and low cytotoxicity, which are crucial for advancements in medical and pharmaceutical applications.
Latest Patents
Takeshi Ido holds a patent for a "Peptide lipid-containing carrier and method for introducing compound into cells using same." This invention provides a carrier capable of highly efficiently introducing a compound into cells with low cytotoxicity. The carrier contains peptide lipids represented by a specific formula, which includes amino acids or peptides and hydrocarbon groups. This innovative approach enhances the delivery of compounds into cells, paving the way for improved therapeutic methods.
Career Highlights
Throughout his career, Takeshi Ido has worked with reputable organizations, including the Fukuoka Prefectural Government and Kyoto University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to various research initiatives.
Collaborations
Some of his notable coworkers include Munetaka Ishiyama and Satoko Yamashita. Their collaborative efforts have likely enriched the research environment and fostered innovative solutions in their respective fields.
Conclusion
Takeshi Ido's contributions to biotechnology through his innovative patent and collaborative work highlight his importance as an inventor. His focus on creating efficient and low-toxicity carriers for compound delivery demonstrates a commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile